Fresh analysis indicates that patients who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who halt conventional lifestyle plans.
Published data in a major health publication demonstrates that while overweight people can lose substantial amounts of their total mass while on the medication, the mass is regained at an average rate of nearly a kilo each month after stopping.
"Users using such medications need to be aware of the risk of quick weight regain when the treatment is stopped," warns expert Dr. Susan Jebb.
That rate of recovery suggests a return to pre-treatment weight within about a year and a half.
Comparing Treatments
The research, which looked at dozens of trials involving thousands of participants, contrasted the effects of the injectable medications with other pills.
Scientists point out that individuals who shed pounds through diet and exercise usually have a more gradual creep back—approximately 0.1 kg a month—post-intervention.
The Reason for the Rapid Rebound
Nutrition scientists believe the mode of action of the jabs is key to understanding the heightened weight return.
These medications imitate a body's own chemical called GLP-1, which controls feelings of fullness.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production may cause the system to produce less of its endogenous hormone, and may also lessen sensitivity to its actions," said Dr. Adam Collins, a nutrition expert.
"Discontinuation of this hormone supplement leads to appetite is unsuppressed, making excessive eating a significant risk."
A Chronic Issue?
The NHS advise the injections for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Professionals say that, considering the significant potential of weight regain, the treatment might need to be ongoing.
This view is supported by pharmaceutical companies, who state that the results "highlight the persistent nature of excess weight," similar to managing conditions like diabetes.
User Testimonies
People who have discontinued the jabs report a powerful return of cravings.
"It felt as if a trigger activating and you're instantly starving," recalled one woman.
This challenge is compounded if individuals have not adopted sustainable lifestyle or habit changes during treatment.
Widespread Use
Figures suggest that millions of people in the UK have tried weight-loss jabs in the past year, with interest remaining high.
- Adoption is greater among females than males.
- The middle-aged demographic shows the highest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than the NHS.
In conclusion, clinicians caution that while GLP-1 drugs are potent tools for shedding pounds, they are not a magic fix and long-term success likely depends on ongoing behavioural support.
